Ultime notizie per Mynaric (NASDAQ:MYNA) Azioni

Mynaric

Mynaric AG operates in the communication equipment business sector. The company is engaged in the manufacture and sale of products and projects and the provision of services in the field of laser technology, in particular in the aerospace, telematics, and satellite services sectors. It operates in two segments: Air and Space. The space segment comprises CONDOR terminals, and the Air segment comprises HAWK terminals. The company's product portfolio consists of Optical ground stations, Air-to-ground terminals, Air-to-air terminals, Space terminals, and Custom products and subcomponents. Its applications consist of high-altitude networks, remote eyes, satellite constellations, earth observation satellites, and others. Geographically, its key revenue is derived from the United States.

Mynaric AG

News

Contracts

AAPL

GSAT

Globalstar Amends Services Agreement With Apple To Launch Extended MSS Network With New Satellites And Infrastructure; Apple To Provide $1.1B Infrastructure Prepayment And Purchase 20% Stake For $400M; Agreement Includes Equity Repurchase Provisions, Performance-Based Service Fees, And Revised Debt Repayment Terms

Major technology firms are encountering a surprising trend where surpassing Wall Street estimates is not enough to satisfy investors. This has led to a decline in stock prices, despite positive earnings reports.
What Happened: Major technology companies are experiencing a paradox where surpassing Wall Street estimates is insufficient to satisfy investors.
On Thursday, Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported quarterly revenue exceeding expectations by $1 billion and an 11% increase in net income compared to the previous year.
Despite these impressive figures, Microsoft&#8217;s <a href="https://www.benzinga.com/news/earnings/24/10/41654118/microsoft-stock-is-sliding-thursday-whats-going-on">shares fell by 6.1%</a> due to a conservative forecast for the upcoming quarter, marking its worst performance since October 26, 2022, CNBC <a href="https://www.cnbc.com/2024/11/01/cnbc-daily-open-big-tech-needs-to-go-beyond-beating-expectations-.html">reported</a> on Friday.
Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) faced similar investor reactions. Despite exceeding Wall Street estimates, the stock began sliding down during Friday pre-market due to investors concerns about weak guidance for December quarter sales. 
Even Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), which initially saw a nearly 3% rise in shares following its earnings report on Wednesday, experienced a <a href="https://www.benzinga.com/news/24/10/41663190/openai-rolls-out-chatgpt-search-google-shares-slide">1.9% decline on Thursday</a> after OpenAI announced rolling out of Chat GPT Search, a competition for Google Search.
See Also: <a href="https://www.benzinga.com/markets/equities/24/10/41615718/cathie-woods-sky-high-vision-dumps-shares-of-cybercab-touting-tesla-for-this-evtol-play?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Cathie Wood&#8217;s Sky-High Vision: Dumps Shares Of Cybercab Touting Tesla For This eVTOL Play</a>
Ross Mayfield, an investment strategist at Baird Private Wealth Management, commented on the situation, stating, "I think we're getting to the point where AI enthusiasm and potential is not enough. These companies are not quite delivering the growth that is priced into them." 
Why It Matters: The comment comes at a time when companies like Microsoft, Apple and Meta are banking on the AI buzz. <a href="https://www.benzinga.com/markets/equities/24/10/41643178/microsofts-ai-business-set-to-hit-10b-revenue-milestone-in-q2-satya-nadella-says-it-is-the-faste">Microsoft&#8217;s AI Business</a> is on track to surpass $10 billion in annual revenue, marking a significant milestone.
CEO Satya Nadella emphasized the rapid adoption of AI across Microsoft&#8217;s product portfolio, highlighting strong customer demand.
Jim Cramer noted that Alphabet&#8217;s plans to increase AI infrastructure investments next year <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41625103/jim-cramer-says-googles-ai-investment-next-year-should-be-fabulous-for-nvidia">could significantly benefit</a> NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). Alphabet&#8217;s recent earnings report revealed a 15% revenue increase, underscoring its strategic focus on technology advancements.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41642374/cathie-wood-shuffles-her-tech-deck-continues-dumping-tesla-and-palantir-stocks-up-on-amd-and-met?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Cathie Wood Shuffles Her Tech Deck: Continues Dumping Tesla And Palantir, Stocks Up On AMD And Meta</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Images via Shutterstock, Edited via Canva

Analyst Color

Equities

Markets

Tech

General

GOOGL

MSFT

NVDA

Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: 'AI Enthusiasm And Potential Is Not Enough"

<a href="https://www.whitehouse.gov/briefing-room/statements-releases/2024/11/01/statement-from-president-joe-biden-on-the-october-2024-jobs-report/" title="https://www.whitehouse.gov/briefing-room/statements-releases/2024/11/01/statement-from-president-joe-biden-on-the-october-2024-jobs-report/">https://www.whitehouse.gov/briefing-room/statements-releases/2024/11/01/statement-from-president-joe-biden-on-the-october-2024-jobs-report/</a>

Macro Notification

Biden, Responding To October Jobs Data, Says Job Growth Is Expected To Rebound In November; Adds ' There's More Work To Do'; Says Hurricanes, Strike Activity Lowered Job Growth

On Thursday, ESSA Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPIX#NASDAQ">EPIX</a>) announced its plans to terminate the Phase 2 trial of masofaniten combined with enzalutamide versus enzalutamide single agent in patients with metastatic castration-resistant prostate cancer (mCRPC) naïve to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41669391/essa-pharma-announces-termination-of-phase-2-study-evaluating-masofaniten-combined-with-enzalutami" rel="noreferrer noopener">second-generation antiandrogens</a>.
This decision was based on a protocol-specified interim review of the safety, PK, and efficacy data, which showed a much higher rate of PSA90 response in patients treated with Pfizer Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) Xtandi (enzalutamide) monotherapy (which is the standard of care for this patient population) than expected based on historical data.
In addition, there was no clear efficacy benefit seen with the combination of masofaniten plus enzalutamide compared to enzalutamide single agent.
A futility analysis determined a low likelihood of meeting the prespecified primary endpoint of the study.
The combination of masofaniten plus enzalutamide was well-tolerated with no new safety signals and a safety profile similar to that seen in Phase 1 studies.
&#8220;We made the difficult decision to terminate this Phase 2 study following the interim analysis because we concluded that the emerging efficacy profile of masofaniten combined with enzalutamide would not likely meet the primary endpoint of the study, nor our internal requirements for a prostate cancer therapy candidate,&#8221; said&nbsp;David Parkinson, President, and CEO.
As part of the effort to focus its resources, ESSA is also planning to terminate the other remaining company-sponsored and investigator-sponsored clinical studies evaluating masofaniten either as a monotherapy or in combination <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/n40862721/essa-pharma-presents-updated-phase-12-masofaniten-epi-7386-clinical-data-at-the-2024-esmo-congress" rel="noreferrer noopener">with other agents</a>.
As of&nbsp;September 30, 2024, the company had available cash reserves and short-term investments of&nbsp;$126.8 million&nbsp;and net working capital of&nbsp;$124.3 million.
In September, ESSA Pharma announced the presentation of updated dose escalation data from its Phase 1/2 study of masofaniten (formerly EPI-7386) in combination with enzalutamide at the 2024 European Society for Medical Oncology (ESMO) Congress.
Across all dose cohorts, 88% of patients (14 of 16) achieved PSA50, 88% of patients (14 of 16) achieved PSA90, 69% of patients (11 of 16) achieved PSA90 in less than 90 days, and 63% of patients (10 of 16) achieved PSA &lt;0.2ng/mL.
Price Action: EPIX stock was down 69.80% at $1.57 during the premarket session at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/24/11/41685490/nvidias-run-ai-acquisition-draws-european-regulatory-scrutiny-on-competition-concerns" target="_blank" rel="noreferrer noopener">Nvidia&#8217;s Run: ai Acquisition Draws European Regulatory Scrutiny On Competition Concerns</a></li>
</ul>

Biotech

Health Care

Movers

EPIX

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) shares are trading lower after the company reported worse-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41679038/lyondellbasell-reports-third-quarter-2024-earnings" rel="noreferrer noopener">third-quarter results</a>.
LYB reported revenues of $10.332 billion, down 2.8% year over year and missing the consensus of $10.601 billion.
Adjusted EBITDA stood at $1.21 billion (-14.1% Y/Y), and the margin contracted by 154 bps to 11.7%. Adjusted EPS stood at $1.88, <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">below the consensus of $1.98.</a>
North American polyethylene margins rose due to lower ethane and gas costs, with demand up over 7% year-to-date. High cracker operating rates boosted third-quarter&nbsp;ethylene volumes, while Europe and Asia margins benefited from lower feedstock costs.
LyondellBasell generated $670 million operating cash flow in the third quarter, with 80% cash conversion over 12 months.
The company invested $368 million in capital expenditures, returned $479 million to shareholders, and held $2.6 billion in cash with $7.3 billion in liquidity.
LyondellBasell&#8217;s CEO, Peter Vanacker, announced that the company started construction on its new MoReTec-1 facility in Germany, a key step toward a sustainable future.
Q4 Outlook: LyondellBasell anticipates softer demand in the fourth quarter due to seasonality, with sequentially higher natural gas and ethane feedstock&nbsp;costs likely impacting North American integrated&nbsp;polyolefins margins.
Operating rates are projected at 85% for North American O&amp;P assets, 60% for European O&amp;P, and 75% for I&amp;D assets, with easing interest rates expected to boost durable goods demand in 2025.
&#8220;Despite challenging global macroeconomic conditions, our strong North American operations allowed us to capitalize on favorable ethylene margins in the region,&#8221; said Vanacker.
Price Action: LYB shares traded lower by 0.98% at $86.00 premarket at the last check Friday.

Earnings

Guidance

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

Oppenheimer analyst Edward Yang maintains Onto Innovation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) with a Outperform and raises the price target from $260 to $275.

Price Target

Analyst Ratings

ONTO

Oppenheimer Maintains Outperform on Onto Innovation, Raises Price Target to $275

Oppenheimer analyst Jed Kelly maintains LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) with a Outperform and raises the price target from $65 to $70.

TREE

Oppenheimer Maintains Outperform on LendingTree, Raises Price Target to $70

Keybanc analyst Alex Markgraff maintains Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Overweight and raises the price target from $515 to $580.

Keybanc Maintains Overweight on Mastercard, Raises Price Target to $580

Oppenheimer analyst Leland Gershell maintains argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Outperform and raises the price target from $560 to $646.

ARGX

Oppenheimer Maintains Outperform on argenx, Raises Price Target to $646

Oppenheimer analyst Michael Phillips maintains Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) with a Outperform and raises the price target from $165 to $177.

Oppenheimer Maintains Outperform on Hanover Insurance Gr, Raises Price Target to $177

JP Morgan analyst Doug Anmuth maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Neutral and lowers the price target from $60 to $58.

EBAY

JP Morgan Maintains Neutral on eBay, Lowers Price Target to $58

The U.S. Securities and Exchange Commission (SEC) announced Thursday that it has charged two affiliates of JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) in five separate enforcement actions resulting in penalties and voluntary payments to investors of <a href="https://www.benzinga.com/markets/equities/24/10/41590849/jpmorgan-sues-customers-over-infinite-money-glitch-that-went-viral-on-tiktok-theyre-held-account">more than $151 million. </a>
The Details: The SEC<a href="https://www.sec.gov/newsroom/press-releases/2024-178"> charged</a> J.P. Morgan Securities LLC and J.P. Morgan Investment Management Inc. in five separate enforcement actions. Among the violations the agency flagged: misleading disclosures to investors, breach of fiduciary duty, prohibited joint transactions and principal trades, and failures to make recommendations in the best interest of customers. 
The JPMorgan affiliates agreed to pay more than $151 million in combined civil penalties and voluntary payments to investors to resolve the actions. The firm did not admit nor deny the findings in the SEC's orders. 
Read Next: <a href="https://www.benzinga.com/markets/asia/24/10/41656452/alibabas-strong-singles-day-sales-kickoff-hints-at-china-consumer-rebound">Alibaba&#8217;s Strong Singles&#8217; Day Sales Kickoff Hints At China Consumer Rebound</a>
"JPMorgan's conduct across multiple business lines violated various laws designed to protect investors from the risks of self-dealing and conflicts of interest," said Sanjay Wadhwa, Acting Director of the SEC's Division of Enforcement. 
"With today's settlements, which include multiple self-reports and large voluntary payments to harmed investors, JP Morgan is being held accountable for its regulatory failures," Wadhwa added.&nbsp;
One of the enforcement actions against J.P. Morgan Securities found that the firm made misleading disclosures to customers who invested in its Conduit private funds products which resulted in complaints from clients after the value of certain shares declined significantly.  
As part of the resolution, J.P. Morgan Securities agreed to make a voluntary payment of $90 million to more than 1,500 Conduit investor accounts. It also agreed to pay a civil penalty of $10 million, which will also be distributed to Conduit investors. 
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, JPMorgan shares are up 0.09 % at $222.13 at the time of publication Friday.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41489239/bank-of-america-ceo-cautions-fed-not-to-go-too-fast-or-too-slow-on-interest-rate-cuts">Bank Of America CEO Cautions Fed Not To &#8216;Go Too Fast Or Too Slow&#8217; On Interest Rate Cuts</a></li>
</ul>
Image: Shutterstock&nbsp;

Large Cap

Legal

JPMorgan To Pay Investors $151 Million After SEC Flags 'Various Law Violations'

Oppenheimer analyst Ittai Kidron maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and raises the price target from $230 to $270.

TEAM

Oppenheimer Maintains Outperform on Atlassian, Raises Price Target to $270

JP Morgan analyst Tien-Tsin Huang maintains Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Overweight and lowers the price target from $593 to $580.

JP Morgan Maintains Overweight on Mastercard, Lowers Price Target to $580

Keybanc analyst Justin Patterson maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Overweight and lowers the price target from $90 to $85.

UBER

Keybanc Maintains Overweight on Uber Technologies, Lowers Price Target to $85

Oppenheimer analyst Jason Helfstein maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and raises the price target from $220 to $230.

AMZN

Oppenheimer Maintains Outperform on Amazon.com, Raises Price Target to $230

<ul>
<li>AMZN</li>
<li>INTC</li>
<li>NVDA</li>
<li>AAPL</li>
<li>DJT</li>
<li>SMCI</li>
<li>LOT</li>
<li>AMD</li>
<li>MSFT</li>
<li>META</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

INTC

SMCI

Top 10 Trending Stocks On WallStreetBets As Of November 1, 2024 (Via Swaggy Stocks)

Morgan Stanley analyst Terence Flynn maintains Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Equal-Weight and lowers the price target from $130 to $123.

Morgan Stanley Maintains Equal-Weight on Merck & Co, Lowers Price Target to $123

NRIM

Northrim BanCorp Acquires Sallyport Commercial Finance In All Cash Transaction Valued At $53.9M

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4292490-1&amp;h=325971108&amp;u=https%3A%2F%2Fwww.aon.com%2Fen%2F&amp;a=Aon+plc">Aon plc</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), a leading global professional services firm, today announced the signing of a definitive agreement to acquire UK-based insurance broker Griffiths &amp; Armour. Upon completion of the transaction, Griffiths &amp; Armour will become wholly-owned by Aon UK Limited and is proposed to go to market as "Griffiths &amp; Armour, an Aon company".
The acquisition closely aligns with Aon's strategy to further expand its presence in the UK and Ireland. The combination will provide a greater breadth of solutions for clients across both Aon and Griffiths &amp; Armour with complementary strengths that create a platform for further growth in the UK, Ireland and beyond. Together, Aon and Griffiths &amp; Armour share a strong cultural alignment through an unwavering focus on clients and colleagues.

Aon To Acquire UK-Based Insurance Broker Griffiths & Armour; Financial Terms Not Disclosed

What Is Going On With Mynaric?

Warning: MYNA is at high risk of performing badly

Mynaric reports preliminary FY results

Mynaric AG (MYNA) Q4 2023 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Many cheap stocks under $10 are cheap for a good reason. Cash-burning biotechs, sketchy shell companies and overhyped fads with more sizzle than substance. But amidst the minefield of duds, there are always a few diamonds in the rough with legitimate 10-bagger potential.



I&rsquo;ve sifted through the bargain bin to bring you seven of the most promising cheap stocks under $10 that I think could multiply. That said, the upside prospect also means there is a significant downside potential too. But I have found picks that have low dilution and could realistically deliver multibagger returns if the stars align for them. These stocks could definitely hit a home run if the best-case scenario unfolds for their underlying businesses. If not, prepare to stomach the losses. Let&rsquo;s take a look!



<h2>Aemetis (AMTX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/12/amtx-stock-1-300x169.jpg" alt="A magnifying glass zooms in on the website for Aemetis (AMTX)."><div>Source: Pavel Kapysh / Shutterstock.com</div></div>Aemetis (NASDAQ:<a href="https://investorplace.com/stock-quotes/amtx-stock-quote/">AMTX</a>) develops and commercializes technologies that replace petroleum-based products with renewable fuels. The company&rsquo;s stock has been on a wild ride, with shares plummeting over 50% in the past year amid continued losses.



However, I believe Aemetis may be nearing an inflection point. The stock has started to stabilize and trade sideways recently. Analysts expect Aemetis to turn profitable within two years on the back of explosive revenue growth. Further, they <a href="https://seekingalpha.com/symbol/AMTX/earnings/estimates" target="_blank">expect sales to surge 90% </a>this year to $354 million. Looking further out, the company&rsquo;s updated five year plan ambitiously targets revenues <a href="https://finance.yahoo.com/news/aemetis-announces-updated-five-plan-130000260.html" target="_blank">reaching $1.95 billion by 2028</a>. That&rsquo;s a robust 38% compound annual growth rate. This revenue spike could lead to a breakout.



H.C. Wainwright analyst Amit Dayal recently reiterated a &ldquo;Buy&rdquo; rating and a $28 price target, highlighting Aemetis&rsquo; &ldquo;<a href="https://www.nasdaq.com/articles/aemetis-amtx-fuels-expectations-falls-short" target="_blank">notable year-on-year revenue growth</a>.&rdquo; While this price target may prove overly optimistic, it&rsquo;s not hard to envision Aemetis stock multiplying several times over if the company meets expectations.



Of course, execution risk abounds for this speculative renewable energy play. Aemetis will need to rapidly scale its dairy renewable natural gas operations and successfully bring its sustainable aviation fuel plant online. Perhaps the cheap stock is worth the risk.



<h2>Nerdy (NRDY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/02/chinese-online-learning-300x169.png" alt="Image of a young girl raising her hand in front of a laptop."><div>Source: MIA Studio / Shutterstock.com</div></div>Nerdy (NYSE:<a href="https://investorplace.com/stock-quotes/nrdy-stock-quote/">NRDY</a>) is an innovative online learning platform that uses AI to connect students with expert tutors for personalized live instruction. The company recently reported first-quarter 2024 results, with <a href="https://www.investing.com/news/stock-market-news/earnings-call-nerdy-inc-reports-strong-q1-growth-aims-for-10m-us-students-93CH-3428192" target="_blank">revenue of $53.7 million</a> beating expectations and marking a 9% year-over-year increase.



I believe Nerdy is well-positioned to capitalize on the growing trend of AI-enhanced learning. AI can be a game-changer when it comes to understanding complex topics like math. The patience and adaptability of AI-powered tutoring is unmatched. If this type of learning becomes more mainstream, I see huge potential for Nerdy to deliver multibagger returns for investors.



Analysts seem to agree, with a consensus &ldquo;<a href="https://www.tipranks.com/stocks/nrdy/forecast" target="_blank">Moderate Buy</a>&rdquo; rating and an average 12-month price target of $4.46, implying 155% upside from the current stock price. While the financials aren&rsquo;t perfect, with the company still reporting losses, the top-line growth remains solid, and the losses appear manageable. Plus, Nerdy reaffirmed its full-year 2024 revenue guidance of $232-246 million and expects to generate positive operating cash flow.



<h2>Blacksky Technology (BKSY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/10/shutterstock_1034855800-300x169.png" alt="A photo of a satellite over earth."><div>Source: AlexLMX / Shutterstock</div></div>BlackSky Technology (NYSE:<a href="https://investorplace.com/stock-quotes/bksy-stock-quote/">BKSY</a>) provides real-time geospatial intelligence and satellite imagery analytics. Though it missed analyst estimates, the company saw <a href="https://finance.yahoo.com/news/q1-2024-blacksky-technology-inc-023814821.html" target="_blank">32% year-over-year revenue growth</a> to $24.2 million in Q1 2024.



Despite the revenue surge, BlackSky is still unprofitable, posting a net loss of $15.8 million in Q1. Year-to-date, BKSY has fallen 20% as the increasingly competitive space sector proves challenging for many companies to turn profits due to high operating costs. It is now up by 9.6% in the past month, though.



I see reasons for optimism. BlackSky has been winning significant contracts, including a <a target="_blank" href="https://www.fool.com/investing/2023/06/12/why-blacksky-stock-rocketed-higher-today/">$30 million contract</a> in Q1 from new deals and renewals. If this momentum continues, I believe the stock could be poised for a breakout. Notably, some analysts project BlackSky reaching profitability by 2026.



The current consensus among analysts is a <a href="https://www.tipranks.com/stocks/bksy/forecast" target="_blank">&ldquo;Strong Buy&rdquo; rating</a>, with an average price target of $3.17, representing a sizable upside from current cheap levels of around $1.10. While I&rsquo;m encouraged by the bullish sentiment, I also recognize the execution risks in the cutthroat space industry. If BlackSky can defy the odds and emerge as a profitable, growing space player, there could be meaningful gains ahead for investors willing to stomach the volatility of cheap stocks under $10. But that&rsquo;s a big &ldquo;if&rdquo; at this stage.



<h2>Serko (SERKF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/air-travel-1600-300x169.png" alt="Plane travel. Man standing in airport waiting for flight. travel stocks to buy"><div>Source: Olena Yakobchuk / Shutterstock</div></div>Serko (OTCMKTS:<a href="https://investorplace.com/stock-quotes/serkf-stock-quote/">SERKF</a>) is a travel management and expense company. The company recently <a href="https://www.serko.com/blog/serko-reports-fy23-total-income-up-154" target="_blank">reported its full-year 2023 earnings</a>, with &ldquo;total income&rdquo; up 154% to 48 million NZD, beating previous guidance. I&rsquo;m bullish here because it targets corporate travel, a niche that could become very big.



Analysts forecast Serko&rsquo;s revenue to grow at <a href="https://seekingalpha.com/symbol/SERKF/earnings/estimates" target="_blank">around 19% per year</a> over the next three years, outpacing the growth projected for the overall software industry in Oceania.



If management executes well, Serko could become a major player in the years ahead. However, the company&rsquo;s lack of profitability and limited operating history make it a high-risk investment. As with any young company, multibagger returns are possible but far from guaranteed. The same applies to this cheap stock.



<h2>Mynaric (MYNA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/shutterstock_1838922316-300x169.jpg" alt="rural broadband: a cell phone tower over a long stretch of hills and forest"><div>Source: Steve Heap / Shutterstock</div></div>Mynaric (NASDAQ:<a href="https://investorplace.com/stock-quotes/myna-stock-quote/">MYNA</a>) develops laser communication technologies for high-bandwidth, long-distance data transmission between moving objects. The Germany-based company has been making notable strides lately, securing major contracts and achieving key product milestones.



I&rsquo;m particularly bullish on Mynaric&rsquo;s laser communication products for wireless data transfer between aircraft, UAVs, high-altitude platforms and satellites. With the growing importance of these technologies in defense and aerospace, Mynaric looks well-positioned to land contracts in the coming years.



Mynaric also posted <a href="https://in.marketscreener.com/quote/stock/MYNARIC-AG-38495674/news/Mynaric-AG-Reports-Earnings-Results-for-the-Full-Year-Ended-December-31-2023-46764024/" target="_blank">21.89% revenue growth in 2023 to &euro;5.39 million</a>, though losses widened 26.8% to &euro;93.53 million. Analysts <a href="https://seekingalpha.com/symbol/MYNA/earnings/estimates" target="_blank">forecast</a> a whopping 941% revenue surge to $61 million this year and nearly $394 million by 2027. However, profitability is not on the table in the near term.



Again, this is a very high-risk stock due to the losses here. It needs to continuously land contracts to keep up the momentum. Also, more dilution may be needed until it presumably breaks even in 2027 if cash runs out. The underlying tech is good, but you should reconsider a buy if you don&rsquo;t like the risk.



<h2>SSC Security Services (SECUF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/cybersecurity-1600-300x169.jpg" alt="internet security and data protection concept, blockchain and cybersecurity"><div>Source: Song_about_summer / Shutterstock</div></div>SSC Security Services (OTCMKTS:<a href="https://investorplace.com/stock-quotes/secuf-stock-quote/">SECUF</a>) is a publicly traded holding company that provides physical, cyber and electronic security services across Canada. The company has been on an impressive growth trajectory lately, with record revenue and adjusted EBITDA in their latest quarterly results.



In Q2 2024, SSC <a target="_blank" href="https://www.stockwatch.com/News/Item/Z-C!SECU-3554531/C/SECU">posted revenue of $30.4 million</a>, a strong 20.6% increase over the same quarter last year. Adjusted EBITDA also grew 33% to $1.1 million. Personally, I see a lot of potential in SSC Security Services. The need for top-notch physical and cybersecurity is only going to keep increasing in our technology-driven world. With high-profile clients across corporate and government sectors, SSC is well-positioned to capitalize on this demand.



Of course, as with any small and relatively young company, there are risks to consider. Profitability is still inconsistent, competition is fierce and the stock remains thinly traded. However, if SSC can maintain its current growth trajectory and achieve sustained profits, I believe this one of the cheap stocks under $10 that could deliver strong returns in the coming years.



<h2>EzFill Holdings (EZFL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/gasoline_1600-300x169.png" alt="A photo of a row of gasoline pump handles at a pump with the sun shining on them. Gas prices dropping."><div>Source: ThePowerPlant/ShutterStock.com</div></div>EzFill Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/ezfl-stock-quote/">EZFL</a>) is a pioneer in the mobile fuel delivery industry. The company recently announced preliminary unaudited <a href="https://www.stocktitan.net/news/EZFL/ez-fill-announces-preliminary-unaudited-revenues-of-approximately-2-nl32zk4mzr76.html" target="_blank">revenues of approximately $2.6 million</a> for April 2024, a 32% year-over-year increase.



In many circumstances, bringing the gas station directly to consumers and businesses could prove convenient and efficient. Most logistics companies are doing all they can to maximize efficiency, and if constant trips to the pump eat into their bottom line, EzFill&rsquo;s service may be an attractive option.



However, I&rsquo;m hesitant to jump on the EzFill bandwagon just yet. The company&rsquo;s decision to implement a <a href="https://uk.marketscreener.com/quote/stock/EZFILL-HOLDINGS-INC-127040898/news/EzFill-Holdings-to-Implement-1-for-2-5-Reverse-Stock-Split-47446337/" target="_blank">1-for-2.5 reverse stock split</a> in July 2024 to maintain Nasdaq listing compliance gives me pause. The stock has bounced between $3-6 for most of 2024, and analysts seem to be taking a cautious stance.



It&rsquo;s low on my watchlist of cheap stocks under $10 due to the reverse split and dilution, but this is a business model I won&rsquo;t be surprised to see take off.



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/07/7-cheap-stocks-under-10-with-10x-potential-july-2024/">7 Cheap Stocks Under $10 With 10X Potential: July 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Cheap Stocks Under $10 With 10X Potential: July 2024

Mynaric increases loss guidance for 2024, CFO steps down

Mynaric secures $5.5M bridge loan and receipt of $5.5M manufacturing readiness milestone payment

AMTX

BKSY

EZFL

MOYFF

MYNA

NRDY

RKLB

SECUF

SERKF

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mynaric AG - MYNA

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Mynaric AG (MYNA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit with the Schall Law Firm

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Mynaric AG

MYNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Mynaric AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mynaric AG Investors: Company Investigated by the Portnoy Law Firm

MYNARIC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Mynaric AG and Encourages Investors to Contact the Firm

Comments

Mynaric

Notizie

Ultime notizie per Mynaric (NASDAQ:MYNA) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO